Last reviewed · How we verify
CROCIN
At a glance
| Generic name | CROCIN |
|---|---|
| Modality | Oligosaccharide |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Efficacy of "Aquoral Lipo" Artificial Tears in Contact Lens Wearers With Discomfort (NA)
- Follow up Study of Crocin on Cardiac Function Protection in Patients With Breast Cancer Undergoing Neoadjuvant Chemotherapy Based on Color Doppler Ultrasound Combined With Myocardial Zymogram
- Role of Saffron and Chamomile in the Management of Parkinson's Disease (NA)
- Protection of Cardiovascular Function With Crocin in BrEast Cancer Patients Undergoing Radiotherapy and Chemotherapy (NA)
- Crocin Supplementation in CSCR (PHASE1)
- Topical and Oral Regimen for Skin Health (NA)
- The Effects of Crocin Supplementation on Metabolic Parameters, Oxidative Stress, AMP- Activated Protein Kinase and Inflammation-promoting Genes Expression in Peripheral Blood Mononuclear Cells in Patients With Type 2 Diabetes (NA)
- Crosslinked Hyaluronic Acid With Liposomes and Crocin in Dry Eye (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- CROCIN CI brief — competitive landscape report
- CROCIN updates RSS · CI watch RSS